Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI
Kristin Ashby, Wei Vivian Zhuang, A. González-Jiménez, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 333-341
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Antonio Segovia-Zafra, Daniel E. Di Zeo-Sánchez, Carlos Lopez‐Gómez, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 12, pp. 3685-3726
Open Access | Times Cited: 41
Network pharmacology and experimental validation of effects of total saponins extracted from Abrus cantoniensis Hance on acetaminophen-induced liver injury
Jiali He, Leping Chen, Ping Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117740-117740
Closed Access | Times Cited: 5
Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury
Hao Niu, Ismael Álvarez‐Álvarez, Minjun Chen
Liver International (2025) Vol. 45, Iss. 3
Open Access
Geniposidic Acid Targeting FXR “S332 and H447” Mediated Conformational Change to Upregulate CYPs and miR‐19a‐3p to Ameliorate Drug‐Induced Liver Injury
Minqi Fan, Yuanhang Xu, Bingxin Wu, et al.
Advanced Science (2025)
Open Access
A fluorescent optical fiber sensor for real-time, portable detection of alkaline phosphatase activity
Dan Li, Yi Shen, Na Li, et al.
Sensors and Actuators B Chemical (2025), pp. 137568-137568
Closed Access
Alteration of Bile Acids and Omega-6 PUFAs Are Correlated With the Progression and Prognosis of Drug-Induced Liver Injury
Shuang Zhao, Haoshuang Fu, Tianhui Zhou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Rational Design of an Intramolecular Hydrogen Bond Enhanced Fluorescent Probe for Diagnosis of Drug-Induced Liver Injury
Xue Chen, Lei Shi, Xiao‐Yun Ran, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 3, pp. 1059-1068
Closed Access | Times Cited: 3
Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury
Yüting Xiong, Jianfei Wang, Le Li, et al.
iLiver (2024) Vol. 3, Iss. 2, pp. 100095-100095
Open Access | Times Cited: 3
Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study
Chunyan Wang, Ya Deng, Ping Li, et al.
Hepatology (2021) Vol. 75, Iss. 6, pp. 1373-1385
Closed Access | Times Cited: 23
Research progress of small molecule fluorescent probes for liver cancer related enzymes
Xingwei Li, Caixia Yin, Le Zhang, et al.
Dyes and Pigments (2023) Vol. 219, pp. 111631-111631
Closed Access | Times Cited: 8
Liver biopsy for assessment of suspected drug‐induced liver injury in metabolic dysfunction‐associated steatohepatitis clinical trials: Expert consensus from the Liver Forum
Melissa Palmer, David E. Kleiner, Zachary Goodman, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 59, Iss. 2, pp. 201-216
Open Access | Times Cited: 7
Increased Non-MAIT CD161+CD8+ T Cells Display Pathogenic Potential in Chronic HBV Infection
Yu Liu, Wei Wang, Peng Zhu, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 5, pp. 1181-1198
Open Access | Times Cited: 6
A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment
Songjun Ji, Bin Lü, Xinling Pan
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
An optimized machine learning model for predicting hospitalization for COVID-19 infection in the maintenance dialysis population
Shuangshan Bu, Huanhuan Zheng, Shanshan Chen, et al.
Computers in Biology and Medicine (2023) Vol. 165, pp. 107410-107410
Closed Access | Times Cited: 6
Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
Yeong Yeh Lee, V. Shen
Drugs in Context (2023) Vol. 12, pp. 1-5
Open Access | Times Cited: 5
Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification
Hao Niu, Pablo Solís‐Muñoz, Miren García‐Cortés, et al.
Pharmacological Research (2023) Vol. 199, pp. 107030-107030
Open Access | Times Cited: 5
Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors
Lei Xu, Lin Chen, Bin Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
Yüting Xiong, Jianfei Wang, Xiaoxia Niu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Machine Learning to Predict Drug-Induced Liver Injury and Its Validation on Failed Drug Candidates in Development
Fahad Mostafa, Victoria E. Howle, Minjun Chen
Toxics (2024) Vol. 12, Iss. 6, pp. 385-385
Open Access | Times Cited: 1
Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury
Quanxian Liu, Lu Huang, Hong Yan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Highlights of the drug-induced liver injury literature for 2021
Stephanie Woo, Dalal Alhaqqan, Daniel T Gildea, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 8, pp. 767-785
Closed Access | Times Cited: 7
Systematic characterization of the absorbed components of Ligustri Lucidi Fructus and their metabolic pathways in rat plasma by ultra‐high‐performance liquid chromatography‐Q‐Exactive Orbitrap tandem mass spectrometry combined with network pharmacology
Danjie Zhang, Lewen Xiong, Linlin Fang, et al.
Journal of Separation Science (2021) Vol. 44, Iss. 24, pp. 4343-4367
Closed Access | Times Cited: 7
A Meta‐Analysis of 13 Randomized Trials on Traditional Chinese Medicine as Adjunctive Therapy for COVID‐19: Novel Insights into Lianhua Qingwen
Yi Lei, Huizhen Guan, Wenqiang Xin, et al.
BioMed Research International (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 4
Global research trends of drug-induced liver injury (DILI) in the past two decades: a bibliometric and visualized study
Dan Liang, Yanping Guan, Jianhong Zhu, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 8, pp. 8651-8664
Open Access | Times Cited: 5
Azathioprine‐induced vanishing bile duct syndrome: The value of early thiopurine metabolism assessment
Laurent Chouchana, Benoît Terris, Philippe Sogni, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 8, pp. 2625-2630
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top